Skip to main content
Erschienen in: Obesity Surgery 11/2016

29.08.2016 | Review Article

Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss

verfasst von: Gian Franco Adami, Nicola Scopinaro, Renzo Cordera

Erschienen in: Obesity Surgery | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Besides the role in energy storing and body health isolating, adipose tissue produces proteins, the so-called adipokines, with pro-inflammatory or anti-inflammatory actions that contribute to metabolic control and to appetite and energy expenditure regulation. The marked adipose tissue loss following bariatric surgery corresponds to a rearrangement of serum adipokine pattern, with increase of anti-inflammatory and decrease of pro-inflammatory agents. This might play a relevant role in the postoperative improvement of metabolic conditions. However, after surgically induced weight loss, other investigations failed to evidence significant modifications of serum concentration of some adipokines. This review speculates that the composition of adipose tissue lost could influence postoperative changes in some adipokine concentration and that an adequate adipokine pattern plays a pivotal role for the long-term metabolic outcome.
Literatur
1.
Zurück zum Zitat Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80.PubMedCrossRef Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80.PubMedCrossRef
2.
Zurück zum Zitat LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes. 2008;116(Suppl 1):S4–6. doi:10.1055/s-2008-1081488.PubMedCrossRef LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes. 2008;116(Suppl 1):S4–6. doi:10.​1055/​s-2008-1081488.PubMedCrossRef
4.
Zurück zum Zitat Sjöström LV. Mortality of severely obese subjects. Am J Clin Nutr. 1992;55(2 Suppl):516S–23S.PubMed Sjöström LV. Mortality of severely obese subjects. Am J Clin Nutr. 1992;55(2 Suppl):516S–23S.PubMed
6.
Zurück zum Zitat Mason J, Willett WC, Stampfer MJ, et al. Body weight and mortality in women. N Engl J Med. 1995;333:677–85.CrossRef Mason J, Willett WC, Stampfer MJ, et al. Body weight and mortality in women. N Engl J Med. 1995;333:677–85.CrossRef
7.
Zurück zum Zitat Seidell JC, Verschuren WM, van Leer EM, et al. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med. 1996;156:958–63.PubMedCrossRef Seidell JC, Verschuren WM, van Leer EM, et al. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med. 1996;156:958–63.PubMedCrossRef
10.
Zurück zum Zitat Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. doi:10.1136/bmj.f5934.PubMedPubMedCentralCrossRef Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. doi:10.​1136/​bmj.​f5934.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28(10):2406–11.PubMedCrossRef Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28(10):2406–11.PubMedCrossRef
14.
Zurück zum Zitat Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84.PubMedPubMedCentral Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84.PubMedPubMedCentral
15.
Zurück zum Zitat Adami G, Murelli F, Carlini F, Papadia F, Scopinaro N. Long-term effect of biliopancreatic diversion on blood pressure in hypertensive obese patients. Am J Hypertens. 2005;18(6):780–4.PubMedCrossRef Adami G, Murelli F, Carlini F, Papadia F, Scopinaro N. Long-term effect of biliopancreatic diversion on blood pressure in hypertensive obese patients. Am J Hypertens. 2005;18(6):780–4.PubMedCrossRef
16.
Zurück zum Zitat Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg. 2000;10(5):428–35.PubMedCrossRef Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg. 2000;10(5):428–35.PubMedCrossRef
17.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRef Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRef
18.
Zurück zum Zitat Sjöström L, Narbro K, Sjöström CD, et al. Swedish obese subjects study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef Sjöström L, Narbro K, Sjöström CD, et al. Swedish obese subjects study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef
19.
Zurück zum Zitat Forbes GB. Human body composition, growth, aging, nutrition, and activity. Influence of nutrition. New York: Springer; 1987. p. 209–47. Forbes GB. Human body composition, growth, aging, nutrition, and activity. Influence of nutrition. New York: Springer; 1987. p. 209–47.
20.
Zurück zum Zitat Scopinaro N. Biliopancreatic diversion. In: Lucchese M, Scopinaro N, editors. Minimally invasive bariatric and metabolic surgery, principles and technical aspects. New York: Springer; 2015. p. 209–26.CrossRef Scopinaro N. Biliopancreatic diversion. In: Lucchese M, Scopinaro N, editors. Minimally invasive bariatric and metabolic surgery, principles and technical aspects. New York: Springer; 2015. p. 209–26.CrossRef
22.
Zurück zum Zitat Falkén Y, Hellström PM, Holst JJ, Näslund E. Changes in glucose homeostasis after roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011;96(7):2227–35. doi:10.1210/jc.2010-2876.PubMedCrossRef Falkén Y, Hellström PM, Holst JJ, Näslund E. Changes in glucose homeostasis after roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011;96(7):2227–35. doi:10.​1210/​jc.​2010-2876.PubMedCrossRef
23.
Zurück zum Zitat Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084–96. doi:10.1007/s11695-012-0621-4.PubMedCrossRef Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084–96. doi:10.​1007/​s11695-012-0621-4.PubMedCrossRef
25.
Zurück zum Zitat Mingrone G, Nolfe G, Gissey GC, Iaconelli A, Leccesi L, Guidone C, Nanni G, Holst JJ. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia. 2009;52(5):873–81. doi:10.1007/s00125-009-1288-9.PubMedCrossRef Mingrone G, Nolfe G, Gissey GC, Iaconelli A, Leccesi L, Guidone C, Nanni G, Holst JJ. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia. 2009;52(5):873–81. doi:10.​1007/​s00125-009-1288-9.PubMedCrossRef
26.
Zurück zum Zitat Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg. 2007;17(9):1193–8.PubMedCrossRef Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg. 2007;17(9):1193–8.PubMedCrossRef
27.
Zurück zum Zitat Major P, Matłok M, Pędziwiatr M, Migaczewski M, Zub-Pokrowiecka A, Radkowiak D, Winiarski M, Zychowicz A, Fedak D, Budzyński A. Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity. Wideochir Inne Tech Maloinwazyjne. 2015;10(3):458–65. doi:10.5114/wiitm.2015.54003.PubMedPubMedCentral Major P, Matłok M, Pędziwiatr M, Migaczewski M, Zub-Pokrowiecka A, Radkowiak D, Winiarski M, Zychowicz A, Fedak D, Budzyński A. Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity. Wideochir Inne Tech Maloinwazyjne. 2015;10(3):458–65. doi:10.​5114/​wiitm.​2015.​54003.PubMedPubMedCentral
28.
Zurück zum Zitat Beckman LM, Beckman TR, Sibley SD, Thomas W, Ikramuddin S, Kellogg TA, Ghatei MA, Bloom SR, le Roux CW, Earthman CP. Changes in gastrointestinal hormones and leptin after roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr. 2011;35(2):169–80. doi:10.1177/0148607110381403.PubMedPubMedCentralCrossRef Beckman LM, Beckman TR, Sibley SD, Thomas W, Ikramuddin S, Kellogg TA, Ghatei MA, Bloom SR, le Roux CW, Earthman CP. Changes in gastrointestinal hormones and leptin after roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr. 2011;35(2):169–80. doi:10.​1177/​0148607110381403​.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Adami GF, Parodi RC, Papadia F, Marinari G, Camerini G, Corvisieri R, Scopinaro N. Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. Obes Surg. 2005;15(9):1233–7.PubMedCrossRef Adami GF, Parodi RC, Papadia F, Marinari G, Camerini G, Corvisieri R, Scopinaro N. Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. Obes Surg. 2005;15(9):1233–7.PubMedCrossRef
33.
Zurück zum Zitat Samat A, Malin SK, Huang H, Schauer PR, Kirwan JP, Kashyap SR. Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab. 2013;15(10):963–6. doi:10.1111/dom.12118.PubMedCrossRef Samat A, Malin SK, Huang H, Schauer PR, Kirwan JP, Kashyap SR. Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab. 2013;15(10):963–6. doi:10.​1111/​dom.​12118.PubMedCrossRef
34.
Zurück zum Zitat Mans E, Serra-Prat M, Palomera E, Suñol X, Clavé P. Sleeve gastrectomy effects on hunger, satiation, and gastrointestinal hormone and motility responses after a liquid meal test. Am J Clin Nutr. 2015;102(3):540–7. doi:10.3945/ajcn.114.104307.PubMedCrossRef Mans E, Serra-Prat M, Palomera E, Suñol X, Clavé P. Sleeve gastrectomy effects on hunger, satiation, and gastrointestinal hormone and motility responses after a liquid meal test. Am J Clin Nutr. 2015;102(3):540–7. doi:10.​3945/​ajcn.​114.​104307.PubMedCrossRef
35.
36.
Zurück zum Zitat Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A. Biliopancreatic diversion. World J Surg. 1998;22(9):936–46.PubMedCrossRef Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A. Biliopancreatic diversion. World J Surg. 1998;22(9):936–46.PubMedCrossRef
37.
40.
Zurück zum Zitat Biter LU, Gadiot RP, Grotenhuis BA, Dunkelgrün M, van Mil SR, Zengerink HJ, Smulders JF, Mannaerts GH. The sleeve bypass trial: a multicentre randomized controlled trial comparing the long term outcome of laparoscopic sleeve gastrectomy and gastric bypass for morbid obesity in terms of excess BMI loss percentage and quality of life. BMC Obes. 2015;2:30. doi:10.1186/s40608-015-0058-0 .eCollection 2015PubMedPubMedCentralCrossRef Biter LU, Gadiot RP, Grotenhuis BA, Dunkelgrün M, van Mil SR, Zengerink HJ, Smulders JF, Mannaerts GH. The sleeve bypass trial: a multicentre randomized controlled trial comparing the long term outcome of laparoscopic sleeve gastrectomy and gastric bypass for morbid obesity in terms of excess BMI loss percentage and quality of life. BMC Obes. 2015;2:30. doi:10.​1186/​s40608-015-0058-0 .eCollection 2015PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34(1):2–11.PubMedCrossRef Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34(1):2–11.PubMedCrossRef
44.
Zurück zum Zitat Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347–55.PubMedCrossRef Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347–55.PubMedCrossRef
48.
Zurück zum Zitat Bluher M. Importance of adipokines in glucose homeostasis. Diabetes Manage. 2013;3:389–40.CrossRef Bluher M. Importance of adipokines in glucose homeostasis. Diabetes Manage. 2013;3:389–40.CrossRef
52.
53.
Zurück zum Zitat Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627–35.PubMedPubMedCentralCrossRef Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627–35.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Schulz TJ, Huang P, Huang TL, Xue R, McDougall LE, Townsend KL, Cypess AM, Mishina Y, Gussoni E, Tseng YH. Brown-fat paucity due to impaired BMP signaling induces compensatory browning of white fat. Nature. 2013;495(7441):379–83. doi:10.1038/nature11943.PubMedPubMedCentralCrossRef Schulz TJ, Huang P, Huang TL, Xue R, McDougall LE, Townsend KL, Cypess AM, Mishina Y, Gussoni E, Tseng YH. Brown-fat paucity due to impaired BMP signaling induces compensatory browning of white fat. Nature. 2013;495(7441):379–83. doi:10.​1038/​nature11943.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature. 2008;454(7207):1000–4. doi:10.1038/nature07221.PubMedPubMedCentralCrossRef Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature. 2008;454(7207):1000–4. doi:10.​1038/​nature07221.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Gustafson B, Hammarstedt A, Hedjazifar S, Hoffmann JM, Svensson PA, Grimsby J, Rondinone C, Smith U. BMP4 and BMP antagonists regulate human white and beige adipogenesis. Diabetes. 2015;64(5):1670–81. doi:10.2337/db14-1127.PubMedCrossRef Gustafson B, Hammarstedt A, Hedjazifar S, Hoffmann JM, Svensson PA, Grimsby J, Rondinone C, Smith U. BMP4 and BMP antagonists regulate human white and beige adipogenesis. Diabetes. 2015;64(5):1670–81. doi:10.​2337/​db14-1127.PubMedCrossRef
58.
Zurück zum Zitat Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A. 2005;102(30):10610–5.PubMedPubMedCentralCrossRef Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A. 2005;102(30):10610–5.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M, Blüher M. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008;57(2):372–7.PubMedCrossRef Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M, Blüher M. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008;57(2):372–7.PubMedCrossRef
61.
Zurück zum Zitat Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764–71.PubMedCrossRef Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764–71.PubMedCrossRef
62.
Zurück zum Zitat Tokunaga A, Miura A, Okauchi Y, Segawa K, Fukuhara A, Okita K, Takahashi M, Funahashi T, Miyagawa J, Shimomura I, Yamagata K. The-1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects. Endocr J. 2008;55(1):205–12.PubMedCrossRef Tokunaga A, Miura A, Okauchi Y, Segawa K, Fukuhara A, Okita K, Takahashi M, Funahashi T, Miyagawa J, Shimomura I, Yamagata K. The-1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects. Endocr J. 2008;55(1):205–12.PubMedCrossRef
63.
Zurück zum Zitat Goktas Z, Moustaid-Moussa N, Shen CL, Boylan M, Mo H, Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol [Lausanne]. 2013;4:69. doi:10.3389/fendo.2013.00069 .eCollection 2013 Goktas Z, Moustaid-Moussa N, Shen CL, Boylan M, Mo H, Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol [Lausanne]. 2013;4:69. doi:10.​3389/​fendo.​2013.​00069 .eCollection 2013
64.
Zurück zum Zitat Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol. 2004;61(3):332–8.CrossRef Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol. 2004;61(3):332–8.CrossRef
65.
Zurück zum Zitat Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, Di Mario U, Baroni MG. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes. 2002;51(3):860–2.PubMedCrossRef Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, Di Mario U, Baroni MG. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes. 2002;51(3):860–2.PubMedCrossRef
66.
Zurück zum Zitat Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13(1):18–23.PubMedCrossRef Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13(1):18–23.PubMedCrossRef
68.
Zurück zum Zitat Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552–63.PubMedCrossRef Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552–63.PubMedCrossRef
69.
Zurück zum Zitat Gómez-Ambrosi J, Rodríguez A, Catalán V, Ramírez B, Silva C, Rotellar F, Gil MJ, Salvador J, Frühbeck G. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clin Endocrinol. 2008;69(2):208–15.CrossRef Gómez-Ambrosi J, Rodríguez A, Catalán V, Ramírez B, Silva C, Rotellar F, Gil MJ, Salvador J, Frühbeck G. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clin Endocrinol. 2008;69(2):208–15.CrossRef
70.
Zurück zum Zitat Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Müller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011;60(7):1917–25. doi:10.2337/db10-1707.PubMedPubMedCentralCrossRef Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Müller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011;60(7):1917–25. doi:10.​2337/​db10-1707.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Sell H, Blüher M, Klöting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care. 2013;36(12):4083–90. doi:10.2337/dc13-0496.PubMedPubMedCentralCrossRef Sell H, Blüher M, Klöting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care. 2013;36(12):4083–90. doi:10.​2337/​dc13-0496.PubMedPubMedCentralCrossRef
73.
75.
76.
Zurück zum Zitat Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356(15):1517–26.PubMedCrossRef Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356(15):1517–26.PubMedCrossRef
77.
Zurück zum Zitat Dalmas E, Venteclef N, Caer C, Poitou C, Cremer I, Aron-Wisnewsky J, Lacroix-Desmazes S, Bayry J, Kaveri SV, Clément K, André S, Guerre-Millo MT. Cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63(6):1966–77. doi:10.2337/db13-1511.PubMedCrossRef Dalmas E, Venteclef N, Caer C, Poitou C, Cremer I, Aron-Wisnewsky J, Lacroix-Desmazes S, Bayry J, Kaveri SV, Clément K, André S, Guerre-Millo MT. Cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63(6):1966–77. doi:10.​2337/​db13-1511.PubMedCrossRef
79.
Zurück zum Zitat Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance [EGIR]. J Clin Invest. 1997;100(5):1166–73.PubMedPubMedCentralCrossRef Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance [EGIR]. J Clin Invest. 1997;100(5):1166–73.PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Rull A, Camps J, Alonso-Villaverde C, Joven J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 [or CCL2] in the regulation of metabolism. Mediat Inflamm. 2010;2010. doi:10.1155/2010/326580. Rull A, Camps J, Alonso-Villaverde C, Joven J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 [or CCL2] in the regulation of metabolism. Mediat Inflamm. 2010;2010. doi:10.​1155/​2010/​326580.
81.
Zurück zum Zitat Malavazos AE, Cereda E, Morricone L, Coman C, Corsi MM, Ambrosi B. Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur J Endocrinol. 2005;153(6):871–7.PubMedCrossRef Malavazos AE, Cereda E, Morricone L, Coman C, Corsi MM, Ambrosi B. Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur J Endocrinol. 2005;153(6):871–7.PubMedCrossRef
82.
Zurück zum Zitat Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60(3):349–56.PubMedCrossRef Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60(3):349–56.PubMedCrossRef
84.
Zurück zum Zitat Trayhurn P. Adipose tissue in obesity—an inflammatory issue. Endocrinology. 2005;146(3):1003–5.PubMedCrossRef Trayhurn P. Adipose tissue in obesity—an inflammatory issue. Endocrinology. 2005;146(3):1003–5.PubMedCrossRef
89.
Zurück zum Zitat Adami GF, Gradasch R, Andrageheri G, et al. Serum leptin and adiponectin concentration in type 2 diabetic patients in the short and in the long term following biliopancreatic diversion. Obes Surg. 2016. doi:10.1007/s11695-016-2126-z. Adami GF, Gradasch R, Andrageheri G, et al. Serum leptin and adiponectin concentration in type 2 diabetic patients in the short and in the long term following biliopancreatic diversion. Obes Surg. 2016. doi:10.​1007/​s11695-016-2126-z.
90.
Zurück zum Zitat Adami GF, Cordera R, Campostano A, Bressani A, Cella F, Scopinaro N. Serum leptin and weight loss in severely obese patients undergoing biliopancreatic diversion. Int J Obes Relat Metab Disord. 1998;22(8):822–4.PubMedCrossRef Adami GF, Cordera R, Campostano A, Bressani A, Cella F, Scopinaro N. Serum leptin and weight loss in severely obese patients undergoing biliopancreatic diversion. Int J Obes Relat Metab Disord. 1998;22(8):822–4.PubMedCrossRef
91.
Zurück zum Zitat Leyvraz C, Verdumo C, Suter M, Paroz A, Calmes JM, Marques-Vidal PM, Giusti V. Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss. Obes Facts. 2012;5(3):440–51. doi:10.1159/000341137.PubMedCrossRef Leyvraz C, Verdumo C, Suter M, Paroz A, Calmes JM, Marques-Vidal PM, Giusti V. Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss. Obes Facts. 2012;5(3):440–51. doi:10.​1159/​000341137.PubMedCrossRef
92.
Zurück zum Zitat Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12(6):962–71.PubMedCrossRef Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12(6):962–71.PubMedCrossRef
94.
Zurück zum Zitat Marinari GM, Camerini G, Cella F, Scopinaro N, Adami GF. Short-term changes in serum leptin concentration following biliopancreatic diversion. Obes Surg. 2000;10(5):442–4.PubMedCrossRef Marinari GM, Camerini G, Cella F, Scopinaro N, Adami GF. Short-term changes in serum leptin concentration following biliopancreatic diversion. Obes Surg. 2000;10(5):442–4.PubMedCrossRef
95.
Zurück zum Zitat Salani B, Briatore L, Andraghetti G, Adami GF, Maggi D, Cordera R. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity [silver. Spring. 2006;14(9):1511–4. Salani B, Briatore L, Andraghetti G, Adami GF, Maggi D, Cordera R. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity [silver. Spring. 2006;14(9):1511–4.
96.
Zurück zum Zitat Butner KL, Nickols-Richardson SM, Clark SF, Ramp WK, Herbert WGA. Review of weight loss following roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg. 2010;20(5):559–68. doi:10.1007/s11695-010-0089-z.PubMedCrossRef Butner KL, Nickols-Richardson SM, Clark SF, Ramp WK, Herbert WGA. Review of weight loss following roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg. 2010;20(5):559–68. doi:10.​1007/​s11695-010-0089-z.PubMedCrossRef
99.
Zurück zum Zitat Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragón-Alonso A, Pascual-Díaz M, Pérez-Paredes M, Lozano-Almela ML. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22(6):950–5. doi:10.1007/s11695-012-0643-y.PubMedCrossRef Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragón-Alonso A, Pascual-Díaz M, Pérez-Paredes M, Lozano-Almela ML. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22(6):950–5. doi:10.​1007/​s11695-012-0643-y.PubMedCrossRef
100.
Zurück zum Zitat Côté M, Cartier A, Reuwer AQ, Arsenault BJ, Lemieux I, Després JP, Wareham NJ, Kastelein JJ, Boekholdt SM, Khaw KT. Adiponectin and risk of coronary heart disease in apparently healthy men and women [from the EPIC-Norfolk prospective population study]. Am J Cardiol. 2011;108(3):367–73. doi:10.1016/j.amjcard.2011.03.053.PubMedCrossRef Côté M, Cartier A, Reuwer AQ, Arsenault BJ, Lemieux I, Després JP, Wareham NJ, Kastelein JJ, Boekholdt SM, Khaw KT. Adiponectin and risk of coronary heart disease in apparently healthy men and women [from the EPIC-Norfolk prospective population study]. Am J Cardiol. 2011;108(3):367–73. doi:10.​1016/​j.​amjcard.​2011.​03.​053.PubMedCrossRef
101.
Zurück zum Zitat Scopinaro N, Camerini G, Papadia F, Andraghetti G, Cordera R, Adami GF. Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. Surg Obes Relat Dis. 2016;12(4):822–7. doi:10.1016/j.soard.2015.12.011.PubMedCrossRef Scopinaro N, Camerini G, Papadia F, Andraghetti G, Cordera R, Adami GF. Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. Surg Obes Relat Dis. 2016;12(4):822–7. doi:10.​1016/​j.​soard.​2015.​12.​011.PubMedCrossRef
102.
Zurück zum Zitat Hirsch FF, Pareja JC, Geloneze SR, Chaim E, Cazzo E, Geloneze B. Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes. Obes Surg. 2012;22(6):910–7. doi:10.1007/s11695-012-0589-0.PubMedCrossRef Hirsch FF, Pareja JC, Geloneze SR, Chaim E, Cazzo E, Geloneze B. Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes. Obes Surg. 2012;22(6):910–7. doi:10.​1007/​s11695-012-0589-0.PubMedCrossRef
103.
Zurück zum Zitat Chen J, Pamuklar Z, Spagnoli A, Torquati A. Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery. Surg Endosc. 2012;26(5):1476–80. doi:10.1007/s00464-011-2059-5.PubMedCrossRef Chen J, Pamuklar Z, Spagnoli A, Torquati A. Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery. Surg Endosc. 2012;26(5):1476–80. doi:10.​1007/​s00464-011-2059-5.PubMedCrossRef
105.
Zurück zum Zitat Sams VG, Blackledge C, Wijayatunga N et al. Effect of bariatric surgery on systemic and adipose tissue inflammation. Surg Endosc. 2016;30(8):3499–504. doi:10.1007/s00464-015-4638-3. Sams VG, Blackledge C, Wijayatunga N et al. Effect of bariatric surgery on systemic and adipose tissue inflammation. Surg Endosc. 2016;30(8):3499–504. doi:10.​1007/​s00464-015-4638-3.
106.
Zurück zum Zitat Netto BD, Bettini SC, Clemente AP, Ferreira JP, Boritza K, Souza Sde F, Von der Heyde ME, Earthman CP, Dâmaso AR. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg. 2015;25(6):1010–8. doi:10.1007/s11695-014-1484-7.PubMedCrossRef Netto BD, Bettini SC, Clemente AP, Ferreira JP, Boritza K, Souza Sde F, Von der Heyde ME, Earthman CP, Dâmaso AR. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg. 2015;25(6):1010–8. doi:10.​1007/​s11695-014-1484-7.PubMedCrossRef
107.
Zurück zum Zitat Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, Peromingo R, San Millán JL, Escobar-Morreale HF. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg. 2008;18(8):1000–6. doi:10.1007/s11695-007-9369-7.PubMedCrossRef Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, Peromingo R, San Millán JL, Escobar-Morreale HF. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg. 2008;18(8):1000–6. doi:10.​1007/​s11695-007-9369-7.PubMedCrossRef
108.
Zurück zum Zitat García-Fuentes E, García-Almeida JM, García-Arnés J, García-Serrano S, Rivas-Marín J, Gallego-Perales JL, Rojo-Martínez G, Garrido-Sánchez L, Bermudez-Silva FJ, Rodríguez de Fonseca F, Soriguer F. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring). 2007;15(10):2391–5.CrossRef García-Fuentes E, García-Almeida JM, García-Arnés J, García-Serrano S, Rivas-Marín J, Gallego-Perales JL, Rojo-Martínez G, Garrido-Sánchez L, Bermudez-Silva FJ, Rodríguez de Fonseca F, Soriguer F. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring). 2007;15(10):2391–5.CrossRef
109.
Zurück zum Zitat Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426–30.PubMedCrossRef Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426–30.PubMedCrossRef
111.
Zurück zum Zitat Marantos G, Daskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg. 2011;35(9):2022–30. doi:10.1007/s00268-011-1165-9.PubMedCrossRef Marantos G, Daskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg. 2011;35(9):2022–30. doi:10.​1007/​s00268-011-1165-9.PubMedCrossRef
112.
Zurück zum Zitat Jankiewicz-Wika J, Kołomecki K, Cywiński J, Piestrzeniewicz K, Swiętosławski J, Stępień H, Komorowski J. Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients. Endokrynol Pol. 2011;62(2):109–19.PubMed Jankiewicz-Wika J, Kołomecki K, Cywiński J, Piestrzeniewicz K, Swiętosławski J, Stępień H, Komorowski J. Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients. Endokrynol Pol. 2011;62(2):109–19.PubMed
113.
Zurück zum Zitat Moschen AR, Molnar C, Wolf AM, Weiss H, Graziadei I, Kaser S, Ebenbichler CF, Stadlmann S, Moser PL, Tilg H. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol. 2009;51(4):765–77. doi:10.1016/j.jhep.2009.06.016.PubMedCrossRef Moschen AR, Molnar C, Wolf AM, Weiss H, Graziadei I, Kaser S, Ebenbichler CF, Stadlmann S, Moser PL, Tilg H. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol. 2009;51(4):765–77. doi:10.​1016/​j.​jhep.​2009.​06.​016.PubMedCrossRef
114.
Zurück zum Zitat Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, Samaha FF. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci. 2005;9(3):161–5.PubMed Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, Samaha FF. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci. 2005;9(3):161–5.PubMed
115.
Zurück zum Zitat Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ, Garcia-Fuentes E. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg. 2009;19(11):1574–80. doi:10.1007/s11695-009-9955-y.PubMedCrossRef Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ, Garcia-Fuentes E. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg. 2009;19(11):1574–80. doi:10.​1007/​s11695-009-9955-y.PubMedCrossRef
116.
Zurück zum Zitat Krist J, Wieder K, Klöting N, Oberbach A, Kralisch S, Wiesner T, Schön MR, Gärtner D, Dietrich A, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts. 2013;6(1):57–69. doi:10.1159/000348667.PubMedCrossRef Krist J, Wieder K, Klöting N, Oberbach A, Kralisch S, Wiesner T, Schön MR, Gärtner D, Dietrich A, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts. 2013;6(1):57–69. doi:10.​1159/​000348667.PubMedCrossRef
117.
Zurück zum Zitat Chang HM, Lee HJ, Park HS, Kang JH, Kim KS, Song YS, Jang YJ. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring). 2010;18(11):2105–10. doi:10.1038/oby.2010.60.CrossRef Chang HM, Lee HJ, Park HS, Kang JH, Kim KS, Song YS, Jang YJ. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring). 2010;18(11):2105–10. doi:10.​1038/​oby.​2010.​60.CrossRef
118.
Zurück zum Zitat Handisurya A, Riedl M, Vila G, Maier C, Clodi M, Prikoszovich T, Ludvik B, Prager G, Luger A, Kautzky-Willer A. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg. 2010;20(2):198–203. doi:10.1007/s11695-009-9882-y.PubMedCrossRef Handisurya A, Riedl M, Vila G, Maier C, Clodi M, Prikoszovich T, Ludvik B, Prager G, Luger A, Kautzky-Willer A. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg. 2010;20(2):198–203. doi:10.​1007/​s11695-009-9882-y.PubMedCrossRef
119.
Zurück zum Zitat Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006;339(1):430–6.PubMedCrossRef Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006;339(1):430–6.PubMedCrossRef
120.
Zurück zum Zitat Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Weiss H, Patsch JR, Ebenbichler CF. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring). 2008;16(11):2439–44. doi:10.1038/oby.2008.391.CrossRef Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Weiss H, Patsch JR, Ebenbichler CF. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring). 2008;16(11):2439–44. doi:10.​1038/​oby.​2008.​391.CrossRef
121.
Zurück zum Zitat Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92(3):1168–71.PubMedCrossRef Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92(3):1168–71.PubMedCrossRef
124.
Zurück zum Zitat Gaborit B, Jacquier A, Kober F, Abdesselam I, Cuisset T, Boullu-Ciocca S, Emungania O, Alessi MC, Clément K, Bernard M, Dutour A. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol. 2012;60(15):1381–9. doi:10.1016/j.jacc.2012.06.016.PubMedCrossRef Gaborit B, Jacquier A, Kober F, Abdesselam I, Cuisset T, Boullu-Ciocca S, Emungania O, Alessi MC, Clément K, Bernard M, Dutour A. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol. 2012;60(15):1381–9. doi:10.​1016/​j.​jacc.​2012.​06.​016.PubMedCrossRef
127.
Zurück zum Zitat Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care. 2006;29:717–8.PubMedCrossRef Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care. 2006;29:717–8.PubMedCrossRef
128.
Zurück zum Zitat Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36:111–7.PubMedCrossRef Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36:111–7.PubMedCrossRef
129.
Zurück zum Zitat Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015;4(2):287–302. doi:10.1007/s13679-015-0155-x.PubMedCrossRef Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015;4(2):287–302. doi:10.​1007/​s13679-015-0155-x.PubMedCrossRef
130.
Zurück zum Zitat Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015;107(3):320–31. doi:10.1016/j.diabres.2015.01.027.PubMedCrossRef Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015;107(3):320–31. doi:10.​1016/​j.​diabres.​2015.​01.​027.PubMedCrossRef
Metadaten
Titel
Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss
verfasst von
Gian Franco Adami
Nicola Scopinaro
Renzo Cordera
Publikationsdatum
29.08.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2347-1

Weitere Artikel der Ausgabe 11/2016

Obesity Surgery 11/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.